Literature DB >> 4005865

The symptoms of patients treated for Parkinson's disease.

C J Bulpitt, K Shaw, P Clifton, G Stern, J B Davies, J L Reid.   

Abstract

One hundred and eighty-one patients with treated Parkinson's disease completed a self-administered questionnaire on symptoms, and their responses were compared with those of 263 control subjects randomly selected from a general practice population. Nine symptoms were reported by the patients with more than a fivefold excess when compared with the controls. These included jerking of the limbs, shaking of the hands, excessive salivation, poor mental concentration, grimacing, being frozen or rooted to the spot, and hallucinations. Compared with the general control population, the patients did not have an excess of stomach or limb pain, indigestion, headache, or any decrease of interest in sex. This observational survey, unlike a randomised controlled trial, could not ensure that the different treatment groups were comparable in important respects. However, certain associations were apparent; for example, patients receiving both a decarboxylase inhibitor and levodopa tended to report fewer attacks of being frozen to the spot, fewer problems with salivation, and a reduced frequency of defaecation. Patients receiving anticholinergic drugs reported an excess of dry mouth, faintness, and dyskinesia, and fewer hot flushes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005865     DOI: 10.1097/00002826-198506000-00007

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  7 in total

1.  Parkinson's disease: disability, review, and management.

Authors:  W J Mutch; A Strudwick; S K Roy; A W Downie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Measurement of the quality of life in congestive heart failure-Influence of drug therapy.

Authors:  Christopher J Bulpitt; Astrid E Fletcher
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 3.  Health-related quality-of-life measurement in patients with Parkinson's disease.

Authors:  C Jenkinson; R Fitzpatrick; V Peto
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

4.  Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Authors:  Eric H Chudler; Ying Lu
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

5.  The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

Authors:  V Peto; C Jenkinson; R Fitzpatrick; R Greenhall
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

Review 6.  Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.

Authors:  Mathieu Marella; Byoung Boo Seo; Takao Yagi; Akemi Matsuno-Yagi
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

7.  Self-Reported Visual Complaints in People with Parkinson's Disease: A Systematic Review.

Authors:  Iris van der Lijn; Gera A de Haan; Famke Huizinga; Fleur E van der Feen; A Wijnand F Rutgers; Catherina Stellingwerf; Teus van Laar; Joost Heutink
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.